Innovation & Entrepreneurship News

The U.S. Patent and Trademark Office (USPTO) today granted the University of California (UC) and its partners, the University of Vienna and Emmanuelle Charpentier, a new CRISPR-Cas9 patent, bringing the team’s continually expanding patent portfolio to 15.

The U.S. Patent and Trademark Office (USPTO) today awarded the University of California (UC), University of Vienna and Emmanuelle Charpentier a patent for CRISPR-Cas9 that, along with two others awarded this month, brings the team’s comprehensive portfolio of gene-editing patents to 14.

Seven University of California, Berkeley, faculty scientists with novel ideas and an entrepreneurial spirit have been named to the 2019-20 cohort of Bakar Fellows, an honor that gives the fellows the money and time to translate their laboratory breakthroughs into technologies ready for the marketplace.

With water scarcity a growing problem worldwide, University of California, Berkeley, researchers are close to producing a microwave-sized water harvester that will allow you to pull all the water you need directly from the air — even in the hot, dry desert.

The University of California, the University of Vienna and Emmanuelle Charpentier received an 11th U.S. patent involving CRISPR-Cas9, further expanding the reach of UC’s patented technology relating to this revolutionary gene-editing tool.

The University of California has received two new patents for use of the revolutionary CRISPR-Cas9 technology, increasing its gene-editing patent portfolio to 10. Five more are expected to be issued by the U.S. Patent and Trademark Office by the end of the summer.

The U.S. Patent and Trademark Office (USPTO) has awarded a new patent to the University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of producing a genetically modified cell through the introduction of the Cas9 protein, or a nucleic acid encoding the Cas9 protein, as well as a single molecule DNA-targeting RNA. This patent (U.S. 10,351,878) covers the use of this method in a cell.

Professor Richard K. Lyons is UC Berkeley’s first-ever Chief Innovation and Entrepreneurship Officer (CIEO).

From the tiny electronics that power our smartphones to the new medicines that keep us well, a surprising number of the ideas and innovations that drive our economy were born not by corporations, but by federally-funded science, shows a new study led by University of California, Berkeley, researchers.

The pharmaceutical company GlaxoSmithKline (GSK) today announced a five-year collaboration with UC Berkeley and UCSF to establish a laboratory where state-of-the-art CRISPR techniques will be used to explore how gene mutations cause disease, potentially yielding new technologies using CRISPR that would rapidly accelerate the discovery of new medicines.

UC Berkeley is renowned for its history of rebellion, upsetting the status quo and stretching the limits of the way things ought to be. That reputation, when viewed from the outside, has often been seen as negative. But a new ranking listing Berkeley as the No. 1 public school in the world for funded founders — business and tech startups that attract funding almost from inception — suggests Berkeley has turned those qualities into positives.